mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |